News
Zydus Lifesciences on Saturday said the US health regulator has issued six observations after inspecting its Gujarat-based API manufacturing unit. "We wish to inform that the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results